Celebrating 20 years
Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial
Building back better after COVID-19: The research agenda
The wider benefits of SGLT2 inhibitors
Delivering a healthier urban food environment
We asked Associate Professor Abraham Flaxman the question how we can use the Global Burden of Disease study to achieve Sustainable Development Goal 3.2.